{"doi":"10.1111/jvim.16311","title":"<i>Bartonella</i> spp. seroepidemiology and associations with clinicopathologic findings in dogs in the United States","abstract":"BACKGROUND: Improved understanding of Bartonella spp. serology in dogs may aid clinical decision making. OBJECTIVE: Describe demographic and geographic patterns of Bartonella spp. seroreactivity in dogs, and describe hematologic and serum biochemical abnormalities in Bartonella spp. seroreactive and nonseroreactive dogs. ANIMALS: Serum samples from 5957 dogs in the United States, previously submitted to IDEXX Reference Laboratories. METHODS: Serum was tested using 3 indirect ELISAs for B. henselae, B. vinsonii subsp. berkhoffii, and B. koehlerae. Complete blood count and serum biochemistry panel results were reviewed retrospectively. RESULTS: Overall, 6.1% of dogs were Bartonella spp. seroreactive. Toy breeds were less likely to be seroreactive (3.9%) than mixed breeds (7.5%; adjusted odds ratio [aOR], 0.48; 95% confidence interval [CI], 0.32-0.72), and dogs <1 year old were less likely to be seroreactive (3.4%) than dogs 1 to 5.5 years of age (7.3%; aOR, 0.42; 95% CI, 0.23-0.72). Dogs in the West South Central (9.8%) and South Atlantic (8.8%) regions were more likely than dogs elsewhere in the United States to be seroreactive (aOR, 2.22; 95% CI, 1.31-3.87; aOR, 2.44; 95% CI, 1.38-4.36). CONCLUSIONS AND CLINICAL IMPORTANCE: Demographic and geographic findings for Bartonella spp. exposure were broadly comparable to previously reported patterns.","journal":"Journal of Veterinary Internal Medicine","year":2021,"id":204666,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":4,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9235,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2021-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":787502,"name":"Brendon Thatcher","orcid":null,"position":1,"is_corresponding":false},{"id":787503,"name":"Ariel J Carruth","orcid":null,"position":2,"is_corresponding":false},{"id":787504,"name":"Anton Mestek","orcid":null,"position":3,"is_corresponding":false},{"id":478555,"name":"Jesse Buch","orcid":"0000-0001-8733-6014","position":4,"is_corresponding":false},{"id":787064,"name":"Melissa J. Beall","orcid":"0000-0002-8165-5361","position":5,"is_corresponding":false},{"id":492818,"name":"Pradeep Neupane","orcid":"0000-0002-6775-6166","position":6,"is_corresponding":false},{"id":478556,"name":"Ramaswamy Chandrashekar","orcid":"0000-0003-0567-1076","position":7,"is_corresponding":false},{"id":787065,"name":"Edward B. Breitschwerdt","orcid":"0000-0002-5179-3720","position":8,"is_corresponding":false},{"id":415290,"name":"Erin Lashnits","orcid":"0000-0003-0949-5698","position":0,"is_corresponding":true}],"reference_count":60,"raw_metadata":null,"created_at":"2026-07-18T23:51:26.121843Z","pmid":"34788481","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}